Related references
Note: Only part of the references are listed.Adaptive immunity: an emerging player in the progression of NAFLD
Salvatore Sutti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The molecular basis for current targets of NASH therapies
Kamran Qureshi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis
Claudia Tonini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibition of class I HDACs imprints adipogenesis toward oxidative and brown-like phenotype
Alessandra Ferrari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Past, present and future perspectives in nonalcoholic fatty liver disease
Arun J. Sanyal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Targeting epigenetic mechanisms for chronic visceral pain: A valid approach for the development of novel therapeutics
Tijs Louwies et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
Ze Chen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization
Jinjin Peng et al.
THERANOSTICS (2019)
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Sneha Kothari et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
Julia Wattacheril et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View
Christina C. Lindenmeyer et al.
CLINICS IN LIVER DISEASE (2018)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel et al.
HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Ivana Mikolasevic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The Histone Methyltransferase Suv39h2 Contributes to Nonalcoholic Steatohepatitis in Mice
Zhiwen Fan et al.
HEPATOLOGY (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang et al.
NATURE MEDICINE (2017)
CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis
Michiko Itoh et al.
JCI INSIGHT (2017)
Microbiome, inflammation, epigenetic alterations, and mental diseases
Reza Alam et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Histone Deacetylase Inhibitory Approaches for the Management of Osteoarthritis
Chandra K. Singh et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
Scott Friedman et al.
CONTEMPORARY CLINICAL TRIALS (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Histological effects of givinostat in boys with Duchenne muscular dystrophy
Paolo Bettica et al.
NEUROMUSCULAR DISORDERS (2016)
Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation
Vidhi Gaur et al.
CELL REPORTS (2016)
Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis
Martina Korfei et al.
THORAX (2015)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice
Jean-Philippe Pradere et al.
HEPATOLOGY (2013)
From NAFLD to NASH to cirrhosis - new insights into disease mechanisms
Alexander Wree et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Kouichi Miura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
Macrophages: Central regulators of hepatic fibrogenesis and fibrosis resolution
Prakash Ramachandran et al.
JOURNAL OF HEPATOLOGY (2012)
Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases
Vincent Zimmer et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
Elizabeth M. Brunt et al.
HEPATOLOGY (2011)
Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
Wan Huang et al.
DIABETES (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Marie-Luise Berres et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Critical role of Kupffer cells in the management of diet-induced diabetes and obesity
Audrey M. Neyrinck et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
CCR2 Promotes Hepatic Fibrosis in Mice
Ekihiro Seki et al.
HEPATOLOGY (2009)
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE
Zheng Zheng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes
Swati joshi-Barve et al.
HEPATOLOGY (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Share Paper
